CBD Global Sciences, Inc. 
Dog the Bounty Hunter New Website Launches Selling CBD Infused Products 
Provided by CBD Global Sciences 
 
07-Jan-2021 / 13:00 CET/CEST 
 
Dog the Bounty Hunter New Website Launches Selling CBD Infused Products 
Provided by CBD Global Sciences 
 
Denver, CO via NewMediaWire [1] -- CBD Global Sciences, Inc. (OTC: CBDNF) 
(CSE: CBDN) (Frankfurt:GS3), "CBD Global" or the "Company"), today announced 
the launch of the new CBD product line "Dog Unleashed CBD" and new website 
www.dogunleashedcbd.com [2]. 
 
Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new 
CBD brand called 'Dog Unleashed CBD' which has been rolled out with a robust 
line of CBD products aimed at addressing multiple ailments in the human body 
with a holistic approach. Initial sales of Dog Unleashed CBD can be found at 
www.dogunleashedcbd.com [2], an internet sales platform. The product launch 
is timed to coincide with his reality TV docudrama Dog Unleashed, that is 
airing on a subscription-based app and will be streaming online. 
 
The initial product line will offer 12 different SKUs focused on 
multi-flavored tinctures offered in three different strengths 1000MG, 2000MG 
and 3500MG. In addition to the tincture products, Dog will offer both 
lotions and salves and all 12 SKUs are infused with a full spectrum CBD oil 
that is lab tested for quality and accuracy. All products meet established 
state and federal requirements of no more than 0.3% 
delta-9-tetrahydrocannabinol and can be sold in all 50 states. The Company 
will expand the product offerings over the next two quarters in 2021 which 
will include CBD infused confectionary products and a hydration line to 
include multi flavored energy drinks. In addition to web-based sales Dog 
Unleashed CBD will be distributed in conjunction with New Age Beverage into 
its distribution channel that boasts over 5,000 stores serviced today. 
 
Dog the Bounty Hunter (Duane Chapman) has begun enlisting from his 
6,000,000+ followers on multiple social media platforms to sign up for the 
airing of his new season. 
 
Duane 'Dog' Chapman stated, "I can't tell you how grateful I am to have the 
opportunity to bring these products to the market and look forward to a 
collaborative partnership with CBD Global Sciences. This product line is 
something that I have found to relieve my pain and stress and the fact that 
it is grown in a field, not made in a lab, is very important to me." 
 
Brad Wyatt, CEO of CBD Global Sciences, shared "I am very excited to have 
the opportunity to work with Dog and Francie on this CBD project. Over the 
past year I have seen Dog in action, and I can assure you he truly cares 
about his fans and wants to help people feel better with a natural solution 
like CBD." 
 
ABOUT DOG UNLEASHED and DOG UNLEASHED CBD 
 
Dog Unleashed (launching Q2 2021) will be the fourth show that Dog has 
launched. This venue has moved to online streaming and subscription-based 
viewing. While testing the waters on viewership Dog had over 30,000 new 
subscribers with just two Instagram postings about the new show (go to 
www.dogunleashed.com [3] to subscribe). Viewership for the new show is 
expected to beat all previous records. Past shows have set records on three 
different networks, A&E, CMT and WGN, of which he still holds the record for 
the most viewed shows in the past 15 years. Promotional interviews that will 
highlight both the upcoming docudrama and the Dog Unleashed CBD have already 
begun and will continue with several daytime shows including Dr. Oz, Ellen, 
Tamron Hill, Entertainment Tonight and multiple Fox affiliates. Most 
interviews will be completed virtually and through various social media 
platforms due to COVID -19. 
 
ABOUT CBD GLOBAL SCIENCES INC. 
 
CBD Global Sciences, Inc., is a vertically integrated hemp-based CBD 
producer and branding investment vehicle which currently owns two product 
categories, branded under the name AETHICS (www.aethics.com [4]) and 
CANNAOIL (www.cannaoilshop.com [5]), which include CBD Oil tinctures (liquid 
products), CBD capsules, CBD topicals, Hydration products and Confectionary 
products. CBD Global Sciences hemp-derived CBD extracts are sold through 
select distributors, bricks and mortar retailers, and online. 
 
CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, 
grows, and operates irrigated land in Colorado, that grows hemp with 
Colorado water, soil, sun, and nutrients and NEVER sprayed with pesticides 
or chemicals. Our genetics are hand selected and maintained to present the 
best cannabinoid profile with extremely high CBD. 
 
For further information, please contact Bruce Nurse, Investor Relations, 
(888) 401-2239, info@cbdglobalsciences.com 
 
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES 
PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY 
OF THIS RELEASE. 
 
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news 
release includes certain "forward-looking statements" under applicable 
Canadian securities legislation. Forward-looking statements include, but are 
not limited to, statements with respect to future developments and the 
business and operations of the Corporation after the CSE listing. 
Forward-looking statements are necessarily based upon a number of estimates 
and assumptions that, while considered reasonable, are subject to known and 
unknown risks, uncertainties, and other factors which may cause the actual 
results and future events to differ materially from those expressed or 
implied by such forward-looking statements. Such factors include, but are 
not limited to general business, economic, competitive, political, and 
social uncertainties; and delay or failure to receive board, shareholder, or 
regulatory approvals. Readers should not place undue reliance on 
forward-looking statements. The Corporation disclaims any intention or 
obligation to update or revise any forward-looking statements, whether as a 
result of new information, future events or otherwise, except as required by 
law. 
 
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
End of Announcement - EQS News Service 
 
1159099 07-Jan-2021 
 
 
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=ce72922f41830a82719863bad73f4d32&application_id=1159099&site_id=vwd&application_name=news 
2: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=11a7cc8b4b577849ae278788e41b7ea8&application_id=1159099&site_id=vwd&application_name=news 
3: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=ee83a881de2690cfe3b2adf29e02ef38&application_id=1159099&site_id=vwd&application_name=news 
4: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=ee3b393b2f63864a59d415f66ac7b9e7&application_id=1159099&site_id=vwd&application_name=news 
5: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=87a8da40bb2328d3ba5efbf848650802&application_id=1159099&site_id=vwd&application_name=news

(END) Dow Jones Newswires

January 07, 2021 07:00 ET (12:00 GMT)